Lymphotropic therapy of patients with open-angle glaucoma
Автор: Parmankulova Yu.D.
Журнал: Экономика и социум @ekonomika-socium
Рубрика: Основной раздел
Статья в выпуске: 11-1 (90), 2021 года.
Бесплатный доступ
The preservation of visual functions in primary open-angle glaucoma remains one of the most pressing problems in modern ophthalmology. Despite the development of many methods of treating glaucoma, vision loss and even blindness from glaucoma are not uncommon. Over the past 3 decades, the frequency of blindness from glaucoma in our country and other developed countries has been steadily maintained at the level of 15% of the total number of all blind people At the moment, more attention is being paid to a direct-acting neuroprotective drug that directly affects retinal neurons and optic nerve fibers by blocking the main factors of cell damage caused by ischemia.
Lymphotropic therapy, open-angle glaucoma, eye diseases.
Короткий адрес: https://sciup.org/140261177
IDR: 140261177
Список литературы Lymphotropic therapy of patients with open-angle glaucoma
- Kurysheva N. I. Glaucoma optical neuropathy. 2006; 16-20.
- Marchenko L. N. Neuroprotection in diseases of the retina and optic nerve. Minsk: UPIC of the Ministry of Finance 2003; 363.
- Milova S. V., Andrianova E. V. Lympho-tropic regional therapy of patients with glaucoma optic neuropathy. Glaucoma: theories, trends, technologies: collection of scientific articles, 2013; 212-214.
- Nesterov A. P. Glaucoma: main problems, new opportunities. Vestn. ophthalmology 2008; 1: 3-5.
- The use of retinalamine in ophthalmology: handbook for doctors. St. Petersburg. 2005; 20.
- Subbotina I. N., Oborina O. V., Shushkanova N. P. Lymphotropic therapy for inflammatory and dystrophic eye diseases. II Interregional scientific and practical conference with international participation "Fundamental and clinical lymphology - practical healthcare". Perm 2003; 143-146.
- Khavinson V. X, Trofimova S. V., Hokka-nen V. M. Preliminary results of the use of peptide bioregulators in patients with diabetic retinopathy. Ophthalmol. journal. 1998; 5: 393-398.
